Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ADVS Technologies Patent Pending Optimization of Pharmacy Operations Using Automatic Distributed Vending System Enters Final Stages of Approvals
  • USA - English


News provided by

ADVS Technologies

Apr 30, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Я-pharmacy™
Я-pharmacy™

San Diego, CA (PRWEB) April 30, 2014 -- “We are pleased to share that the patent pending Optimization of Pharmacy Operations using Automatic Distributed Vending System (ADVS) is in the final stages of approvals by the United States Patent Office, with all claims being allowed,” according to inventor Zack Braunstein of ADVS Technologies.

“The ADVS,” continues Braunstein, “represents a significant step forward, delivering superior level of customer services, while sustaining high quality of prescription medications, and potentially lowering their costs.”

ADVS represents a significant step forward, delivering superior level of customer services, while sustaining high quality of prescription medications, and potentially lowering their costs.

Post this

The scalable ADVS technology is configurable to provide the most cost effective and efficient support in optimizing operation of all kind and type of pharmacies. Read about the Optimization of Pharmacy Operations using Automatic Distributed Vending System (ADVS) here.

ADVS technology will benefit the CUSTOMER:

• Providing customers with only 100% verified quality medications.
ADVS continuously monitors and ensures that medications are in full compliance to respective specifications.

• Significantly reducing time for customers in obtaining medications.
ADVS dispensing rates approach four medication containers in one second.

Further reduction in time is achieved by scheduling a time window for picking up completed prescriptions at an ADVS-pharmacy™, or visiting a near-by stand-alone ADVS-kiosk™ operating 24 hours. ADVS supports direct delivery of medications to customers, and when compared with other systems, only ADVS-pharmacy.mobile™ insures the delivered medications remained within their specifications at all times.

• Avoiding health risks for customers.
ADVS eliminates waiting in-line in front of pharmacy counters, behind other customers with potentially contagious illnesses.

• Protecting customer sensitive information.
ADVS supports configuration of ADVS-pharmacy.central™ providing centralized processing of prescriptions at a dedicated location operated by highly qualified personnel with support from state-of-the art IT security systems.

ADVS technology will also benefit the PROVIDER:

• Improving efficiency of operations and increasing profit margins.
ADVS is projected of lowering operating costs by minimum of 10%.

• Sustaining quality operations at all times.
ADVS helps to avoid risky “bottle necks” during high demands, such as during flu seasons, and maintains balanced business operation, helping business to avoid “fatigue” during peak demands which can cause operator errors.

• Gaining market share.
ADVS significantly improves customer service, and provides opportunities for providers to lower the price of the medications while sustaining competitive profit margins. ADVS will provide customers with 100% quality medications at convenient locations, including stand-alone ADVS-kiosks™ with 24 hours un-attended services. These key features will continuously attract new customers.

According to Braunstein, once ADVS technology is developed, an investment of as little as $50K can double productivity of a small stand-alone independent pharmacy, while additional $10K will add 24 hours unattended service. This will provide the small businesses with “ammunition” to compete with large scale corporations, while providing unique user-friendly environment. An investment of ~$250K would double productivity of a typical pharmacy, while supporting 24 hours unattended service.

For the ones curious about the name: the letter “R” is “mirrored” toward the customer side, just as the one in the “Я-World™”, emphasizing the intention of providing the best possible service for customers.

About ADVS-Technologies:
ADVS-Technologies is a young and ambitious company specializing in the development of innovative proprietary technologies with an extensive portfolio of patented technology in the areas of illumination systems, power distribution systems, pharmacy, store automation, and transport systems. The objective of ADVS-Technologies is to provide effective and efficient environmentally friendly solutions with the intent of improving quality of services.

For more information, please visit http://www.advs-technologies.com.

Zachary Braunstein, ADVS Technologies, http://www.magicstreetsign.com, +1 760-813-2387, [email protected]

Modal title

Я-pharmacy™
Я-pharmacy™
Я-pharmacy™ Brief Executive Summary
View PDF
Я-pharmacy™ Brief Executive Summary
Я-pharmacy™ Stand Alone Pharmacy
View PDF
Я-pharmacy™ Stand Alone Pharmacy
Я-pharmacy™
View PDF
Я-pharmacy™
Я-World™
Я-World™
Я-pharmacy™ Я-pharmacy™ Brief Executive Summary Я-pharmacy™ Stand Alone Pharmacy Я-pharmacy™ Я-World™

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.